In this setting, metformin blocks both the mTOR signaling pathway and the senescence-associated reprogramming of cancer stemness induced by CDK4/6 inhibitor, a known Jekyll and Hyde of CDK4/6 inhibition in cancer treatment [160]. This evidence concerns the gene CDK4 and cancer.